Johnson & Johnson

J&J likely to seek EU approval for Covid-19 vaccine in February, says lawmaker

US firm Johnson & Johnson is likely to apply for EU approval for its Covid-19 vaccine candidate in February, a top lawmaker said on Wednesday.

Clinical data of the vaccine, which Johnson & Johnson is developing through its subsidiary Janssen, have been assessed by the European Medicines Agency (EMA) since Dec. 1 under a rolling review to speed up possible approval.

A Pharmaceutical Giant Was Condemned for the Opiate Epidemic in the US

An US court has ordered the pharmaceutical giant Johnson and Johnson to pay $ 572 million in compensation for the opiate epidemic.

An Oklahoma judge ruled that the company was responsible for exacerbating the drug problem in the state, flooding the market with painkillers that were misleading patients.

Greek court convicts 13 over orthopedic product procurements

A Greek court has convicted 13 people in connection with alleged corruption during state hospital purchases from DePuy, a subsidiary of US healthcare giant Johnson & Johnson.
The Athens criminal court on Tuesday acquitted another seven people over the same case, in which Greek hospital doctors allegedly took bribes to prescribe DePuy orthopedic products.

Trial over hospital fraud postponed indefinitely

An appeals court in Athens has decided to postpone indefinitely the trial of 24 suspects in connection to the sale of orthopedic equipment to Greek hospitals by DePuy, a subsidiary of Johnson & Johnson, between 2000 and 2006.

The judges decided to call off the trial after accepting an argument from the defense that the suspects had not been notified about the trial promptly.